_JIKK_2024-2.pdf_.png)
2.png)
KAJIAN PUSTAKA: METODE IDENTIFIKASI PENANDA BIOLOGIS FESES PADA KANKER KOLOREKTAL
Sari
Abstrak: Metode Identifikasi Penanda Biologis Feses Pada Kanker Kolorektal. Kanker kolorektal adalah salah satu penyebab kematian utama akibat kanker di seluruh dunia. Kanker kolorektal adalah jenis keganasan dengan tingkat kelangsungan hidup yang berkaitan erat dengan momentum penegakan diagnosis. Temuan klinis yang ditunjang dengan hasil pemeriksaan laboratorium dapat mengawali dugaan akan kanker kolorektal dan mencetus saran untuk pemeriksaan lanjutan, sehingga identifikasi penanda biologis untuk deteksi awal yang tepat menjadi penting. Tinjauan pustaka ini akan membahas mengenai berbagai metode dan tahapan penelitian untuk mengindentifikasi kandidat penanda biologis feses untuk kanker kolorektal.
Kata Kunci
Teks Lengkap:
PDFReferensi
Aebersold, R., & Mann, M. (2003). Mass spectrometry-based proteomics. Nature 2003 422:6928, 422(6928), 198–207. https://doi.org/10.1038/nature01511
Aguilar, M. I. (2004). HPLC of peptides and proteins: basic theory and methodology. Methods in Molecular Biology (Clifton, N.J.), 251, 3–8. https://doi.org/10.1385/1-59259-742-4:3/COVER
Alvarez-Chaver, P., Otero-Estévez, O., Páez de la Cadena, M., Rodríguez-Berrocal, F. J., & Martínez-Zorzano, V. S. (2014). Proteomics for discovery of candidate colorectal cancer biomarkers. World Journal of Gastroenterology, 20(14), 3804–3824. https://doi.org/10.3748/wjg.v20.i14.3804
Ang, C. S., Baker, M. S., & Nice, E. C. (2017). Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers. In Methods in Enzymology (Vol. 586, pp. 247–274). Academic Press Inc. https://doi.org/10.1016/bs.mie.2016.10.019
Davies, R. J., Miller, R., & Coleman, N. (2005). Colorectal cancer screening: Prospects for molecular stool analysis. In Nature Reviews Cancer (Vol. 5, Issue 3, pp. 199–209). https://doi.org/10.1038/nrc1569
de Palma, F. D. E., D’argenio, V., Pol, J., Kroemer, G., Maiuri, M. C., & Salvatore, F. (2019). The molecular hallmarks of the serrated pathway in colorectal cancer. Cancers, 11(7). https://doi.org/10.3390/cancers11071017
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, & Bray F. (2020). Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, 68(6).
Fritsch, R. J., & Krause, I. (2003). ELECTROPHORESIS. Encyclopedia of Food Sciences and Nutrition, 2055–2062. https://doi.org/10.1016/B0-12-227055-X/01409-7
Jasperson, K. W., Tuohy, T. M., Neklason, D. W., & Burt, R. W. (2010). Hereditary and Familial Colon Cancer. Gastroenterology, 138(6), 2044–2058. https://doi.org/10.1053/j.gastro.2010.01.054
Jin, P., Wang, K., Huang, C., & Nice, E. C. (2017). Mining the fecal proteome: from biomarkers to personalised medicine. In Expert Review of Proteomics (Vol. 14, Issue 5, pp. 445–459). Taylor and Francis Ltd. https://doi.org/10.1080/14789450.2017.1314786
Kang, U.-B., Yeom, J., Kim, H.-J., Kim, H., & Lee, C. (2012). Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry. Journal of Proteomics, 75(10), 3050–3062. https://doi.org/10.1016/j.jprot.2011.11.021
Keum, N., & Giovannucci, E. (2019). Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology, 16(12), 713–732. https://doi.org/10.1038/s41575-019-0189-8
Kim, H.-J., Kang, H. J., Lee, H., Lee, S.-T., Yu, M.-H., Kim, H., & Lee, C. (2009). Identification of S100A8 and S100A9 as serological markers for colorectal cancer. Journal of Proteome Research, 8(3), 1368–1379. https://doi.org/10.1021/pr8007573
Lecky, D. M., Hawking, M. K. D., & McNulty, C. A. M. (2014). Patients’ perspectives on providing a stool sample to their GP: a qualitative study. The British Journal of General Practice, 64(628), e684. https://doi.org/10.3399/BJGP14X682261
Ma, Y., Peng, J., Liu, W., Zhang, P., Huang, L., Gao, B., Shen, T., Zhou, Y., Chen, H., Chu, Z., Zhang, M., & Qin, H. (2009). Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Molecular & Cellular Proteomics : MCP, 8(8), 1878–1890. https://doi.org/10.1074/mcp.M800541-MCP200
Mirnezami, R., Spagou, K., Vorkas, P. A., Lewis, M. R., Kinross, J., Want, E., Shion, H., Goldin, R. D., Darzi, A., Takats, Z., Holmes, E., Cloarec, O., & Nicholson, J. K. (2014). Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects. Molecular Oncology, 8(1), 39–49. https://doi.org/10.1016/j.molonc.2013.08.010
Shiromizu, T., Kume, H., Ishida, M., Adachi, J., Kano, M., Matsubara, H., & Tomonaga, T. (2017). Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics. Scientific Reports, 7(1), 12782. https://doi.org/10.1038/s41598-017-13092-x
DOI: https://doi.org/10.33024/jikk.v11i1.13265
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##
Pendidikan Dokter Universitas Malahayati Lampung
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.